Rubella Antibody panel (IgG & IgM)

Rubella Antibody Panel (IgG & IgM)

The Rubella Antibody Panel (IgG & IgM) is a blood test that measures Rubella-specific IgG and IgM antibodies to determine whether a person has immunity to rubella (German measles) or has a recent or current infection.

Rubella is a contagious viral infection caused by the Rubella virus. While the illness is often mild in children and adults, infection during pregnancy—especially during the first trimester—can cause Congenital Rubella Syndrome (CRS), leading to miscarriage, stillbirth, or serious birth defects involving the heart, eyes, ears, and brain. (who.int)

The Rubella Antibody Panel includes:

• Rubella IgG Antibody – Indicates previous infection or successful vaccination and usually reflects immunity.
• Rubella IgM Antibody – Suggests a recent or current rubella infection but should always be interpreted with clinical findings and, when necessary, confirmatory testing.

Common symptoms of rubella include:

• Mild fever
• Pink or red rash
• Swollen lymph nodes (especially behind the ears and neck)
• Joint pain
• Headache
• Fatigue
• Mild conjunctivitis

Many infected individuals, particularly children, may have few or no symptoms.

The Rubella Antibody Panel is commonly requested for:

• Pre-pregnancy immunity assessment
• Routine antenatal screening
• Suspected recent rubella infection
• Investigation of congenital rubella syndrome
• Evaluation of healthcare workers or other individuals requiring immunity documentation

Test Purpose

The Rubella Antibody Panel helps to:

• Determine immunity to rubella.
• Detect recent or current rubella infection.
• Assess immunity before or during pregnancy.
• Evaluate newborns suspected of congenital rubella syndrome.
• Confirm previous vaccination or natural infection.
• Support epidemiological investigations during rubella outbreaks.

Benefits

• Simple blood test requiring only a serum sample.
• Helps protect pregnancies by identifying non-immune individuals.
• Assists in prenatal and preconception care.
• Supports diagnosis of recent rubella infection.
• Useful in vaccination and immunity assessment.
• Helps identify infants with suspected congenital rubella syndrome.

Why Doctors Recommend This Test

Doctors commonly recommend this test for:

• Women planning pregnancy.
• Pregnant women during antenatal care.
• Patients with symptoms suggestive of rubella.
• Infants suspected of congenital rubella syndrome.
• Healthcare workers requiring immunity documentation.
• Individuals exposed to confirmed rubella cases.

Preparation Before the Test

No fasting or special preparation is required.

Inform your healthcare provider about:

• Pregnancy status
• Recent rubella vaccination
• Recent viral illness
• Previous rubella infection
• Immunodeficiency disorders
• Current medications

A blood sample is collected from a vein for laboratory analysis.

Normal Reporting Time

Typically: 2–5 Working Days

Reporting time may vary depending on the laboratory methodology.

Who Should Take This Test?

This test may be recommended for:

• Women planning pregnancy.
• Pregnant women.
• Individuals without documented rubella vaccination.
• Patients with suspected rubella infection.
• Infants with suspected congenital rubella syndrome.
• Healthcare workers.
• Close contacts of confirmed rubella cases.
• Patients with unexplained rash illness.
• Individuals requiring proof of rubella immunity.
• Anyone advised by their healthcare provider.